For citations:
Chuchalin A.G., Yablonskiy P.K., Rubanik T.V., Chernyavskaya O.A., Naumov V.V., Korneva L.I., Kudelуa L.M., Petukhova A.Yu., Masalkina O.V., Argamakova Yu.V., Ignatova G.L., Borisov A.G., Kasyanova T.R., Suleymanova A.K. Efficacy and safety of bovhyaluronidase azoximer (Longidase) in patients with post-COVID syndrome: results of an open, prospective, controlled, comparative, multicenter clinical trial DISSOLVE. PULMONOLOGIYA. 2023;33(1):52-63. (In Russ.) https://doi.org/10.18093/0869-0189-2023-33-1-52-63
Email this article 